Genotoxic effects of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline (MeIQ) in rats measured by alkaline elution

Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in colon and liver of Big Blue rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress

The contribution of oxidative stress, different types of DNA damage and expression of DNA repair enzymes in colon and liver mutagenesis induced by 2-amino-3-methylimidazo [4,5-f]quinoline (IQ) was investigated in four groups of six Big Blue rats fed diets with 0, 20, 70, and 200 mg IQ/kg for 3 weeks. There were dose-response relationships of DNA adducts ((32)P-postlabeling) and DNA strand breaks (comet assay) in colon and liver tissues, with the highest levels of DNA adducts and strand breaks in the colon. There was dose-dependent induction of mutations in both the colon and the liver, and the same IQ dose produced two-fold more cII mutations in the liver compared with the colon. The IQ-induced mutation spectrum in the colon was not significantly different to that of control rats. The expression of ERCC1 and OGG1 was higher in the colon than liver, and was unaffected by the IQ diet. Investigations of oxidative stress biomarkers produced inconclusive results. Oxidative DNA damage detected by the endonuclease III enzyme and 7-hydro-8-oxo-2'-deoxyguanosine in colon, liver and/or urine was unaltered by IQ. However, there was increased level of gamma-glutamyl semialdehyde in liver proteins, indicating a higher rate of protein oxidation in the liver following IQ administration. In plasma and erythrocytes there were unaltered levels of oxidized protein, malondialdehyde, and antioxidant enzyme activities (superoxide dismutase, glutathione peroxidase, catalase, glutathione reductase) indicating no systemic oxidative stress. However, the level of total vitamin C was increased in plasma, with the largest fraction being in the reduced form. In conclusion, our results indicate that DNA adducts rather than oxidative stress are responsible for the initiation of IQ-induced carcinogenesis of the liver and colon. A lower frequency of mutations in the colon than in the liver could be related to higher expression of DNA repair enzymes in the former.

Evaluation of fecal mutagenicity and colorectal cancer risk

Colorectal cancer is one of the most common internal malignancies in Western society. The cause of this disease appears to be multifactorial and involves genetic as well as environmental aspects. The human colon is continuously exposed to a complex mixture of compounds, which is either of direct dietary origin or the result of digestive, microbial and excretory processes. In order to establish the mutagenic burden of the colorectal mucosa, analysis of specific compounds in feces is usually preferred. Alternatively, the mutagenic potency of fecal extracts has been determined, but the interpretation of these more integrative measurements is hampered by methodological shortcomings. In this review, we focus on exposure of the large bowel to five different classes of fecal mutagens that have previously been related to colorectal cancer risk. These include heterocyclic aromatic amines (HCA) and polycyclic aromatic hydrocarbons (PAH), two exogenous factors that are predominantly ingested as pyrolysis products present in food and (partially) excreted in the feces. Additionally, we discuss N-nitroso-compounds, fecapentaenes and bile acids, all fecal constituents (mainly) of endogenous origin. The mutagenic and carcinogenic potency of the above mentioned compounds as well as their presence in feces, proposed mode of action and potential role in the initiation and promotion of human colorectal cancer are discussed. The combined results from in vitro and in vivo research unequivocally demonstrate that these classes of compounds comprise potent mutagens that induce many different forms of genetic damage and that particularly bile acids and fecapentaenes may also affect the carcinogenic process by epigenetic mechanisms. Large inter-individual differences in levels of exposures have been reported, including those in a range where considerable genetic damage can be expected based on evidence from animal studies. Particularly, however, exposure profiles of PAH and N-nitroso compounds (NOC) have to be more accurately established to come to a risk evaluation. Moreover, lack of human studies and inconsistency between epidemiological data make it impossible to describe colorectal cancer risk as a result of specific exposures in quantitative terms, or even to indicate the relative importance of the mutagens discussed. Particularly, the polymorphisms of genes involved in the metabolism of heterocyclic amines are important determinants of carcinogenic risk. However, the present knowledge of gene-environment interactions with regard to colorectal cancer risk is rather limited. We expect that the introduction of DNA chip technology in colorectal cancer epidemiology will offer new opportunities to identify combinations of exposures and genetic polymorphisms that relate to increased cancer risk. This knowledge will enable us to improve epidemiological study design and statistical power in future research.

Chromosome aberrations induced in mice by chronic feeding of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ)

Dietary intake of mutagenic compounds is considered to be an important factor for the induction of some human cancers. Highly mutagenic compounds are known to be formed in meat during the cooking process. Since the discovery of such compounds, many studies have been conducted to evaluate their carcinogenic potential. One of the most mutagenic compounds formed in the cooking of meat is 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). The recent development of mouse chromosome painting probes expand the capability of evaluating these food mutagens as potential clastogens in vivo. In this paper, we demonstrate the induction of chromosome aberrations in mice chronically exposed to MeIQ in their diet. CDF1 female mice were fed 400 ppm MeIQ beginning at 7 wk of age. At 76 wk of age, five control and eight exposed mice were euthanized. Blood and bone marrow cells were obtained and arrested in metaphase. Whole chromosome painting probes were used for fluorescence in situ hybridization of metaphase cells from blood and bone marrow. MeIQ-exposed mice were found to have a twofold increase in translocations and a 16-fold increase in fragments in their peripheral blood compared with controls. No aberrations were observed in the bone marrow. All organs were examined for the presence of tumours and routine histopathological analysis was performed on all organs as well as any tissue with macroscopic abnormalities. Forestomach and/or liver tumours developed in all but one of the mice fed MeIQ, but no such tumours were observed in the control mice. These data indicate that MeIQ is clastogenic and carcinogenic in vivo.

Organ-specific and transplacental DNA damage and its repair in rats treated with 1,2-dibromo-3-chloropropane

An in vivo genotoxicity assay system based on alkaline elution has been used to study the formation and removal of DNA damage induced by 1,2-dibromo-3-chloropropane (DBCP). Cells/nuclei from different tissues and organs of Wistar rats were prepared by a rapid mincing/homogenization technique. Thirty-six samples of which up to 11 were from different organs of the same animal, were then assayed in parallel for DNA damage (DNA single-strand breaks plus alkali-labile sites = SSBs) with a semi-automated alkaline elution system. A single i.p. injection of DBCP gave dose-(5 and 10 mg/kg) and time-(20 min-4 h) dependent SSBs in kidney and liver DNA from male rats. At 10 mg/kg DBCP, SSBs were formed in all organs examined except the bone marrow and colon; however, an increased dose of 40 mg/kg produced SSBs also in the latter two organs. The relative susceptibilities to DBCP-induced DNA damage were: kidney approximately duodenum > liver > lung approximately brain approximately urinary bladder approximately glandular stomach > spleen approximately testis > bone marrow approximately colon. These relative levels correlate with previous data on tissue distribution and organ necrosis in liver, kidney and testis of rats given a single i.p. dose of DBCP. When female rats were injected i.p. with 5, 10 or 20 mg/kg (nonhepatotoxic doses) at day 20 of pregnancy, similar levels of SSBs were detected in the livers of the dam and the fetuses. In adult male rats, time-dependent changes in SSBs were followed in the liver and kidney after DBCP exposure. In both organs SSBs peaked around 4 h post-exposure, 50% had been removed by 12-24 h, whereas at day 2-3 SSB frequencies had returned to control levels. Pretreatment of rats with phenobarbital prior to DBCP exposure reduced the maximum level of DNA damage as well as its persistence. In cultured primary hepatocytes from male rats exposed in vitro to DBCP (2-20 microM. 1 h), 50% of the initial DNA damage had been repaired within approximately 100 min. In conclusion, the experiments indicate that the distribution characteristics of DBCP are of major importance for DNA damage and its persistence in various organs of rats. The data are also in accordance with glutathione-S-transferase, rather than P450, being the most important pathway for metabolic activation of DBCP in rat extrahepatic tissues including the fetal liver. It appears that alkaline elution of cells/nuclei prepared from exposed animals constitutes a sensitive, rapid and versatile technique to study organ- and cell-specific genotoxicity in vivo.

Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities. A literature review

This review summarizes the abundant literature on food-borne heterocyclic amines, their chemistry and formation, their occurrence in food, their biological activities including mutagenicity, induction of DNA damage and carcinogenicity. Pharmacokinetics and biotransformation are also discussed. Factors that influence these effects are given consideration, with special emphasis on dietary factors that might counteract detrimental biological effects. The annual per capita intake of heterocyclic amines via food is estimated. Risk extrapolations that have been published suggest that food-borne heterocyclic amines are relevant for human cancer etiology.